Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters

PURPOSE: Since the introduction of ipilimumab (IPI) for the treatment of patients with metastatic malignant melanoma, we have observed remarkable responses after hypofractionated whole brain irradiation (WBRT) or stereotactic radiotherapy (STX) for brain metastases of malignant melanoma. We sought t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidberger, Heinz, Rapp, Matthias, Ebersberger, Anne, Hey-Koch, Silla, Loquai, Carmen, Grabbe, Stephan, Mayer, Arnulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267133/
https://www.ncbi.nlm.nih.gov/pubmed/30298365
http://dx.doi.org/10.1007/s00066-018-1356-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267133/
https://www.ncbi.nlm.nih.gov/pubmed/30298365
http://dx.doi.org/10.1007/s00066-018-1356-5

Ejemplares similares